Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Does early (treatment in) BENEFIT lead to late MS benefit?
IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study.
Internet-Supported Physical Exercise Training for Persons with Multiple Sclerosis-A Randomised, Controlled Study.
Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Contribution of EAE to understanding and treating multiple sclerosis.
Assessing Four Quality Indicators for Multiple Sclerosis Management Through Patient-Reported Data.
Hospital admission rates for pediatric multiple sclerosis in the United States using the Pediatric Health Information System (PHIS).
A decade of natalizumab and PML: Has there been a tacit transfer of risk acceptance?
Clinical Application of Autologous Adipose Stem Cells in Patients with Multiple Sclerosis: Preliminary Results.
Activity-dependent calcium signalling in oligodendrocyte generation.
Cerebral Microbleeds in Multiple Sclerosis Evaluated on Susceptibility-weighted Images and Quantitative Susceptibility Maps: A Case-Control Study.
Risk of Autoimmunity in EoE and Families: A Population-Based Cohort Study.
Autoimmunity meets genetics: Multiple sclerosis in a patient with Kallmann syndrome.
Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system.
Identification of gene expression patterns critically involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions.
Protandim Protects Oligodendrocytes against an Oxidative Insult.
Two novel variants in CNTNAP1 in two siblings presenting with congenital hypotonia and hypomyelinating neuropathy.
Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force.
Clinical Utility of Mindfulness Training in the Treatment of Fatigue After Stroke, Traumatic Brain Injury and Multiple Sclerosis: A Systematic Literature Review and Meta-analysis.
Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
The Oligodendrocyte-Specific Antibody "CC1" Binds Quaking 7.
Microbiomic and Posttranslational Modifications as Preludes to Autoimmune Diseases.
Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.

Pages